Ries, A., Flehberger, D., Slany, A., Pirker, C., Mader, J. C., Mohr, T., Schelch, K., Sinn, K., Mosleh, B., Hoda, M. A., Dome, B., Dolznig, H., Krupitza, G., Müllauer, L., Gerner, C., Berger, W., & Grusch, M. (2023). Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. Journal of Experimental and Clinical Cancer Research, 42(1), [27]. https://doi.org/10.1186/s13046-022-02582-0

Janker, L., Schuster, D., Bortel, P., Hagn, G., Meier-Menches, S. M., Mohr, T., Mader, J. C., Slany, A., Bileck, A., Brunmair, J., Madl, C., Unger, L., Hennlich, B., Weitmayr, B., Del Favero, G., Pils, D., Pukrop, T., Pfisterer, N., Feichtenschlager, T., & Gerner, C. (2023). Multi-omics empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states. Journal of Crohn's & colitis, 17(9), 1514-1527. https://doi.org/10.1093/ecco-jcc/jjad052

Ries, A., Slany, A., Pirker, C., Mader, J. C., Mejri, D., Mohr, T., Schelch, K., Flehberger, D., Maach, N., Hashim, M., Hoda, M. A., Dome, B., Krupitza, G., Berger, W., Gerner, C., Holzmann, K., & Grusch, M. (2023). Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. Cells, 12(15), [2006]. https://doi.org/10.3390/cells12152006

Muqaku, B., Pils, D., Mader, J. C., Aust, S., Mangold, A., Muqaku, L., Slany, A., Del Favero, G., & Gerner, C. (2020). Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer. Cancers, 12(2), [505]. https://doi.org/10.3390/cancers12020505

Janker, L., Mayer, R. L., Bileck, A., Kreutz, D., Mader, J. C., Utpatel, K., Heudobler, D., Agis, H., Gerner, C., & Slany, A. (2019). Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia. Molecular & cellular proteomics : MCP, 18(5), 936-953. https://doi.org/10.1074/mcp.RA119.001390

Mayer, R. L., Schwarzmeier, J. D., Gerner, M. C., Bileck, A., Mader, J. C., Meier-Menches, S. M., Gerner, S. M., Schmetterer, K. G., Pukrop, T., Reichle, A., Slany, A., & Gerner, C. (2018). Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia. Molecular and Cellular Proteomics, 17(2), 290-303. [UNSP RA117.000425]. https://doi.org/10.1074/mcp.RA117.000425

Meier, S. M., Kreutz, D., Winter, L., Klose, M. H. M., Cseh, K., Weiss, T., Bileck, A., Alte, B., Mader, J. C., Jana, S., Chatterjee, A., Bhattacharyya, A., Hejl, M., Jakupec, M. A., Heffeter, P., Berger, W., Hartinger, C. G., Keppler, B. K., Wiche, G., & Gerner, C. (2017). An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin. Angewandte Chemie (International Edition), 56(28), 8267-8271. https://doi.org/10.1002/anie.201702242

Meier, S. M., Muqaku, B., Ullmann, R., Bileck, A., Kreutz, D., Mader, J. C., Knasmueller, S., & Gerner, C. (2015). Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone. PLoS ONE, 10(10), [e0140367]. https://doi.org/10.1371/journal.pone.0140367